Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Survival returned 140 record(s)
|
|
Sunday, 07/29/2018
|
Flexible Accelerated Failure Time Model in Survival Analysis
Menglan Pang, McGill University; Michal Abrahamowicz, McGill University; Robert W Platt, McGill University
|
Inference for Fine-Gray Competing Risks Model with High-Dimensional Covariates
Jue Hou, UCSD Biostatistics; Jelena Bradic, UC San Diego; Ronghui Xu, UC San Diego
|
Temporally Dependent Accelerated Failure Time Model for Capturing the Impact of Events That Alter Survival in Disease Mapping
Rachel Carroll, National Institute of Environmental Health Sciences; Andrew B Lawson, Medical University of South Carolina ; Shanshan Zhao, National Institute of Environmental Health Sciences
|
An Innovative Approach to Identify Biomarker Signatures for Cancer Genetic Data with Survival Endpoints
Ming Wang, Pennsylvania State University; Zheng Li, Penn State Unviersity
|
Survival Analysis Methods for Characterizing B-Cell Mutation Processes
David A. Shaw, Fred Hutchinson Cancer Research Center; Jean Feng, University of Washington; Vladimir N. Minin, University of California, Irvine; Noah Simon, University of Washington; Erick A. Matsen, Fred Hutchinson Cancer Research Center
|
Competing Risks Matter in the Analysis of Public Health Data: When and How?
Dahhay Lee, National Cancer Center; Hyunsoon Cho, National Cancer Center
|
Flexible and Interpretable Models for Survival Data
Jiacheng Wu, Univesity of Washington; Daniela Witten, University of Washington
|
A Gaussian Copula Approach for Dynamic Prediction of Survival with a Longitudinally Measured Marker
Krithika Suresh, University of Michigan; Jeremy M.G. Taylor, University of Michigan; Alexander Tsodikov, University of Michigan
|
Regression Calibration to Address Error Prone Time-To-Event Outcomes
Eric Oh, University of Pennsylvania; Pamela A Shaw, University of Pennsylvania
|
Adjusting for Covariate Measurement Error in Failure Time Analysis Under Competing Risks
Carrie Caswell, University of Pennsylvania; Sharon X Xie, University of Pennsylvania
|
Matching Methods for Evaluating the Effect of a Time-Dependent Treatment on the Survival Function
Danting Zhu, University of Michigan; Douglas E. Schaubel, University of Michigan, Ann Arbor
|
Sample Size Calculations for Non-Inferiority Trials Using the Concept of Proportional Time
Milind A Phadnis, University of Kansas Medical Center
|
Regression Calibration to Address Error Prone Time-To-Event Outcomes
Eric Oh, University of Pennsylvania; Pamela A Shaw, University of Pennsylvania
2:05 PM
|
A Gaussian Copula Approach for Dynamic Prediction of Survival with a Longitudinally Measured Marker
Krithika Suresh, University of Michigan; Jeremy M.G. Taylor, University of Michigan; Alexander Tsodikov, University of Michigan
2:10 PM
|
Adjusting for Covariate Measurement Error in Failure Time Analysis Under Competing Risks
Carrie Caswell, University of Pennsylvania; Sharon X Xie, University of Pennsylvania
2:15 PM
|
Statistical Development in Addressing Delayed Treatment Effect or Crossing Survival Curves in Immuno-Oncology Clinical Trials
Huyuan Yang, Takeda Oncology Pharmaceutical
2:20 PM
|
Optimal Timing of Stem Cell Transplant for Leukemia Patients
Xuelin Huang, University of Texas MD Anderson Cancer Center; Ruosha Li, University of Texas School of Public Health; Jorge Cortes, University of Texas MD Anderson Cancer Center
2:25 PM
|
Flexible and Interpretable Models for Survival Data
Jiacheng Wu, Univesity of Washington; Daniela Witten, University of Washington
2:30 PM
|
An Adaptive Test of Significance in the Presence of Uncertainty in the Timing of the Final Analysis
Jeremy Gorelick, Edwards Lifesciences
2:35 PM
|
Cure Survival Data in Oncology Studies
Shih-Yuan Lee, Takeda
2:35 PM
|
Temporally Dependent Accelerated Failure Time Model for Capturing the Impact of Events That Alter Survival in Disease Mapping
Rachel Carroll, National Institute of Environmental Health Sciences; Andrew B Lawson, Medical University of South Carolina ; Shanshan Zhao, National Institute of Environmental Health Sciences
2:45 PM
|
An Innovative Approach to Identify Biomarker Signatures for Cancer Genetic Data with Survival Endpoints
Ming Wang, Pennsylvania State University; Zheng Li, Penn State Unviersity
2:50 PM
|
Survival Analysis Methods for Characterizing B-Cell Mutation Processes
David A. Shaw, Fred Hutchinson Cancer Research Center; Jean Feng, University of Washington; Vladimir N. Minin, University of California, Irvine; Noah Simon, University of Washington; Erick A. Matsen, Fred Hutchinson Cancer Research Center
3:00 PM
|
Competing Risks Matter in the Analysis of Public Health Data: When and How?
Dahhay Lee, National Cancer Center; Hyunsoon Cho, National Cancer Center
3:05 PM
|
Correlation Between the Time-To-Event Endpoints in Prostate Cancer Clinical Trials
Susan Li, Janssen R&D
3:05 PM
|
Inference for Fine-Gray Competing Risks Model with High-Dimensional Covariates
Jue Hou, UCSD Biostatistics; Jelena Bradic, UC San Diego; Ronghui Xu, UC San Diego
3:15 PM
|
Semiparametric Regression Methods for Temporal Processes Subject to Multiple Sources of Censoring
Douglas E. Schaubel, University of Michigan, Ann Arbor; Tianyu Zhan, AbbVie Inc.
3:25 PM
|
Sample Size Calculations for Non-Inferiority Trials Using the Concept of Proportional Time
Milind A Phadnis, University of Kansas Medical Center
3:25 PM
|
Matching Methods for Evaluating the Effect of a Time-Dependent Treatment on the Survival Function
Danting Zhu, University of Michigan; Douglas E. Schaubel, University of Michigan, Ann Arbor
3:45 PM
|
Robust Modeling of Survival Curves in the Presence of Time-Varying Effects
Jorne Biccler, Aalborg University Hospital; Tim Verdonck, KU Leuven; Stefan Van Aelst, KU Leuven; Martin Bøgsted, Aalborg University
4:05 PM
|
Kaplan-Meier Based Methods to Address Non-Proportional Hazard Issues
Bo Huang, Pfizer Inc.
4:05 PM
|
Design and Analysis of Survival Trials with Treatment Crossover
Xiaodong Luo, Sanofi
4:25 PM
|
A Hybrid Approach for Prediction of Event Times in Double-Blind Clinical Trials
Ming Zhu, Sanofi Pasteur; Yunnan Xu, Virginia Tech; Zheng Su, Deerfield Institute
5:05 PM
|
An Approach to Predict Final Yield Among Interim Cases
Rui Jiao, Westat; Andrea Piesse, Westat
5:20 PM
|
|
Monday, 07/30/2018
|
SurvBoost: An R Package for High-Dimensional Variable Selection in the Stratified Proportional Hazards Model via Gradient Boosting
Emily Morris, University of Michigan; Jian Kang, University of Michigan; Zhi He, University of Michigan; Yanming Li, University of Michigan; Yi Li, University of Michigan
|
Median Regression for Clustered, Interval Censored Data
Piyali Basak, Florida State University; STUART LIPSITZ, HARVARD MEDICAL SCHOOL; Debajyoti Sinha, Florida State University
|
Nonparametric Testing for Multiple Survival Functions with Non-Inferiority Margins
Hsin-wen Chang, Academia Sinica; Ian W. McKeague, Columbia University
|
Comparisons of Modeling Methods on Longitudinal and Survival Data: Identifying Use of Repeat Biomarker Measurements to Predict Time-To-Event Outcome in Cancer Research
Meng Ru, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
|
Quantile-Optimal Treatment Regimes with Censored Data
Yu Zhou, University of Minnesota; Lan Wang, University of Minnesota; Rui Song, North Carolina State University
|
Survival Analysis Using Intensive Longitudinal Data and Irregular Moments of Reporting
Trent Lalonde, Applied Statistics Program, University of Northern Colorado; Kristina T Phillips, University of Northern Colorado; Michael M Phillips, University of Northern Colorado
|
A Comparison of Methods to Estimate Survival Curves Under Time-Varying Treatments
Lucia C. Petito, Harvard T.H. Chan School of Public Health; Sonja A. Swanson, Erasmus Medical Center; Miguel Hernan, Harvard School of Public Health
|
A Bayesian Semiparametric Joint Model for Longitudinal and Survival Data
Pengpeng Wang, Florida State University; Jonathan R. Bradley, Florida State University; Elizabeth H. Slate, Florida State University
|
Modeling a Longitudinal Covariate as Continuous Time Markov Chain in a Survival Framework
Ting-Yu Chen, The University of Texas Health Science Center at Houston; Wenyaw Chan, University of Texas Health Science Center at Houston; Qiuling Shi, The University of Texas MD Anderson Cancer Center; Xin Shelley Wang, The University of Texas MD Anderson Cancer Center; Charles Cleeland, The University of Texas MD Anderson Cancer Center
|
Assessing Therapeutic Equivalence of Brand and Generic Drugs Using Observational Data
Lamar Hunt, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Daniel Scharfstein, Johns Hopkins University; Irene Murimi, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Jodi Segal, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Ravi Varadhan, Johns Hopkins University; Ramin Mojtabai, Johns Hopkins Bloomberg SPH
|
Quantile-Optimal Treatment Regimes with Censored Data
Yu Zhou, University of Minnesota; Lan Wang, University of Minnesota; Rui Song, North Carolina State University
9:15 AM
|
Instrumental Variable Methods for Comparing Cancer Survival Outcomes
Fei Wan, University of Arkansas for Medical Sciences; Dylan Small, University of Pennsylvania; Nandita Mitra, University of Pennsylvania
9:35 AM
|
Comparison of Event Rates Between On- and Off-Drug Treatment Periods for a Recurrent Adverse Event
Brenda Crowe, Eli Lilly & Co.; Haoda Fu, Eli Lilly and Company; Yebin Tao, Eli Lilly and Company
9:35 AM
|
Survival Analysis Applied to Agricultural Sciences
Jung Ae Lee, University of Arkansas Agriculture Statistics Laboratory
9:35 AM
|
Left-Censored Data: the Orphan Child of Survival Analysis
Brenda Gillespie, Univ of Michigan
9:50 AM
|
Closed-Form Solutions for Group Sequential Design in Survival Trials with Non-Proportional Hazards
Jianliang Zhang, Medimmune, LLC; Erik Pulkstenis, AbbVie
10:05 AM
|
A Comparison of Methods to Estimate Survival Curves Under Time-Varying Treatments
Lucia C. Petito, Harvard T.H. Chan School of Public Health; Sonja A. Swanson, Erasmus Medical Center; Miguel Hernan, Harvard School of Public Health
10:45 AM
|
Modeling a Longitudinal Covariate as Continuous Time Markov Chain in a Survival Framework
Ting-Yu Chen, The University of Texas Health Science Center at Houston; Wenyaw Chan, University of Texas Health Science Center at Houston; Qiuling Shi, The University of Texas MD Anderson Cancer Center; Xin Shelley Wang, The University of Texas MD Anderson Cancer Center; Charles Cleeland, The University of Texas MD Anderson Cancer Center
10:45 AM
|
A Bayesian Semiparametric Joint Model for Longitudinal and Survival Data
Pengpeng Wang, Florida State University; Jonathan R. Bradley, Florida State University; Elizabeth H. Slate, Florida State University
11:00 AM
|
Variable Selection in Partially Linear Additive Hazards Model with Grouped Covariates and a Diverging Number of Parameters
Xuewen Lu, University of Calgary; Arfan Afzal, University of Calgary
11:15 AM
|
Comparisons of Modeling Methods on Longitudinal and Survival Data: Identifying Use of Repeat Biomarker Measurements to Predict Time-To-Event Outcome in Cancer Research
Meng Ru, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
11:15 AM
|
Survival Analysis Using Intensive Longitudinal Data and Irregular Moments of Reporting
Trent Lalonde, Applied Statistics Program, University of Northern Colorado; Kristina T Phillips, University of Northern Colorado; Michael M Phillips, University of Northern Colorado
11:40 AM
|
Assessing Therapeutic Equivalence of Brand and Generic Drugs Using Observational Data
Lamar Hunt, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Daniel Scharfstein, Johns Hopkins University; Irene Murimi, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Jodi Segal, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Ravi Varadhan, Johns Hopkins University; Ramin Mojtabai, Johns Hopkins Bloomberg SPH
12:10 PM
|
Nonparametric Generalized Fiducial Inference for Survival Functions Under Censoring
Yifan Cui, University of North Carolina at Chapel Hill; Jan Hannig, University of North Carolina
2:05 PM
|
Considering Delayed Treatment Effect in Trial Designs with Survival Endpoints
Kaushal Mishra, Novartis Oncology Pharmaceuticals; Kalyanee Viraswami Appanna, Novartis Pharmaceuticals
2:20 PM
|
Are Tumor Size Changes Predictive of Survival for Immunotherapy Trials?
Meihua Wang, Merck & Co.; Thomas Jemielita, Merck & Co.; Cong Chen, Merck & Co.; Chen Hu, Johns Hopkins University
2:35 PM
|
Does Phase 2 PFS or ORR Predict Phase 3 OS?
Russell Reeve, Quintiles
2:50 PM
|
Goodness-of-Fit Tests in Proportional Hazards Models with Random Effects
Ingrid Van Keilegom, KU Leuven; Wenceslao Gonzalez Manteiga, University of Santiago de Compostela; Maria Dolores Martinez Miranda, University of Granada
2:55 PM
|
Joint Modeling of Length-Biased and Competing Risks Survival Times with View Toward Individualized Prediction: An Application to Spontaneous Labor
Rajeshwari Sundaram, Eunice Kennedy SHriver National Institute of Child Health and Human Development; Ling Ma, Clemson University
3:20 PM
|
Penalized Shrinkage Estimation in Reduced-Rank Time-To-Event Data
Ananda Sen, University of Michigan
3:25 PM
|
|
Tuesday, 07/31/2018
|
Generating Survival Times Using Cox Proportional Hazards Models with Cyclic Time-Varying Covariates
Yunda Huang, Fred Hutchinson Cancer Research Center; Lily Zhang, Fred Hutchinson Cancer Research Center; Zong Zhang, Interlake High School; Peter Gilbert, Fred Hutchinson Cancer Research Center
|
On Survival Tree Under the Dependency Between Failure and Censoring
Asanao Shimokawa, Tokyo University of Science; Etsuo Miyaoka, Tokyo University of Science
|
Firth Adjustment for Parametric Current-Status Survival Analysis
Hung-Mo Lin, Icahn School of Medicine at Mount Sinai; JOHN M WILLIAMSON, Centers for Disease Control and Prevention; HAE-YOUNG KIM, New York Medical College
|
Proteomics and Genomics Integration and Ovarian Cancer Survival
Umut Ozbek, Icahn School of Medicine at Mount Sinai; Christopher Conley, University of California at Davis; Jie Peng, UC Davis; Pei Wang, Icahn School of Medicine at Mount Sinai
|
Determination of Optimal Cut-Off Points for Biomarkers in Oncology Research
Shu-Pang Huang, Bristol-Myers Squibb Co.; Tian Chen, Bristol-Myers Squibb Co.; Ye Feng, Bristol-Myers Squibb Co.; Ming Zhou, Bristol-Myers Squibb Company; Ramachandran Suresh, Bristol-Myers Squibb Co.
|
Method for Evaluating Longitudinal Follow-Up Frequency: Application to Dementia Research
Leah Suttner, University of Pennsylvania; Sharon X Xie, University of Pennsylvania
|
A Machine Learning (ML) Approach to Prognostic and Predictive Covariate Identification for Subgroup Analysis and Hypotheses Generation
David A James, Novartis
|
Supervised Dimension Reduction for Large-Scale Genomic Data with Censored Survival Outcomes Under Possible Non-Proportional Hazards
Lauren Spirko, Temple University; Karthik Devarajan, Fox Chase Cancer Center
|
Model Validation of Time-To-Event Analyzes via the Concordance Statistic
Samantha-Jo Caetano, McMaster University
|
Explore Modified Organ Dysfunction Score System to Improve the Prediction of Survival
Grace Zhang, GSK
|
Correcting for Errors in Variables Derived from Electronic Health Records Using Validation Sampling and Multiple Imputation
Bryan E Shepherd, Vanderbilt University School of Medicine; Mark Giganti, Vanderbilt University School of Medicine
8:35 AM
|
Model Validation of Time-To-Event Analyzes via the Concordance Statistic
Samantha-Jo Caetano, McMaster University
8:40 AM
|
On the Use of Raking to Improve Regression Calibration: A Flexible Method to Address Error-Induced Bias Efficiently
Eric Oh, University of Pennsylvania; Pamela A Shaw, University of Pennsylvania
9:00 AM
|
Systematic Review of Test/Estimation Approach in Comparative Cancer Clinical Studies with Time-To-Event Outcomes
Miki Horiguchi, Kitasato University; Hajime Uno, Dana Farber Cancer Institute
9:05 AM
|
Explore Modified Organ Dysfunction Score System to Improve the Prediction of Survival
Grace Zhang, GSK
9:05 AM
|
Design Considerations in Clinical Trials with Cure Rate Survival Data: a Case Study in Oncology
Grace Liu, Johnson & Johnson; Steven Sun, J&J; Tzu-min Yhe, janssen pharmaceuticals; Tianmeng Lyu, University of Minnesota; Rao Sudhakar, janssen pharmaceuticals; Bruce Xue, Johnson & Johnson China
9:20 AM
|
Using Survival Analysis to Address Attrition and Vacancy Rates at the Food Safety and Inspection Service
Sarah McMillan, Food Safety and Inspection Service / USDA; Anna Frey, Food Safety and Inspection Service / USDA
9:20 AM
|
Multivariate Meta-Analysis Model for the Difference in Restricted Mean Survival Times
Isabelle R Weir, Boston University School of Public Health; Ludovic Trinquart, Boston University School of Public Health
9:35 AM
|
Method for Evaluating Longitudinal Follow-Up Frequency: Application to Dementia Research
Leah Suttner, University of Pennsylvania; Sharon X Xie, University of Pennsylvania
9:35 AM
|
On the Asymptotics of Tree-Based Survival Models
Ruoqing Zhu, University of Illinois Urbana-Champaign; Yifan Cui, University of North Carolina at Chapel Hill; Michael Kosorok, University of North Carolina at Chapel Hill; Mai Zhou, University of Kentucky
9:55 AM
|
Semiparametric Single-Index Models for Optimal Treatment Regimes with Censored Outcomes
Jin Wang, University of North Carolina at Chapel Hill; Danyu Lin, University of North Carolina; Donglin Zeng, UNC Chapel Hill
10:35 AM
|
Supervised Dimension Reduction for Large-Scale Genomic Data with Censored Survival Outcomes Under Possible Non-Proportional Hazards
Lauren Spirko, Temple University; Karthik Devarajan, Fox Chase Cancer Center
11:00 AM
|
Limitations of Progression Free Survival as a Surrogate Marker for Overall Survival in Oncology Trials
Robin Mogg, Merck Research Laboratories; Yiwei Zhang, Merck Research Laboratories
11:15 AM
|
Modeling Overall Survival Under Immuno-Oncology Therapies with Long-Term Survival Models
Junshui Ma, Merck & Co., Inc.; Keaven Anderson, Merck & Co., Inc.
11:35 AM
|
A Machine Learning (ML) Approach to Prognostic and Predictive Covariate Identification for Subgroup Analysis and Hypotheses Generation
David A James, Novartis
11:35 AM
|
Identifying and Validating Surrogate Endpoints for Overall Survial (OS) in Metastatic Castration-Resistant Prostate Cancer
Xiaowei Guan, Pfizer, Inc.; Michelle Casey, Pfizer, Inc.; De Phung, Astellas Pharma, Inc. ; Suha Sari, Pfizer, Inc.; Eren Demirhan, Pfizer, Inc.
11:35 AM
|
Restricted Mean Survival Time as a Function of Restriction Time
Yingchao Zhong, University of Michigan; Douglas E. Schaubel, University of Michigan, Ann Arbor
11:50 AM
|
Maximum Likelihood Estimation of First-Passage Structural Credit Risk Models Correcting for the Survivorship Bias
Mathieu Boudreault, Université du Québec à Montréal; Diego Amaya, Wilfrid Laurier University; Don L. McLeish, University of Waterloo
2:05 PM
|
The Role of Body Mass Index at Diagnosis on Black-White Disparities in Colorectal Cancer Survival: a Density Regression Mediation Approach
Katrina Devick, Harvard TH Chan School of Public Health; Linda Valeri, McLean Hospital, Harvard Medical School; Jarvis Chen, Harvard TH Chan School of Public Health; Alejandro Jara, Pontificia Universidad Catolica de Chile; Marie-Abele Bind, Harvard University; Brent A. Coull, Harvard TH Chan School of Public Health
2:05 PM
|
Measuring Association Between Times from Treatment Initiation to Viral Failure and Regimen Change in HIV-Infected Persons
Svetlana K. Eden, Vanderbilt University School of Medicine; Bryan E Shepherd, Vanderbilt University School of Medicine; Chun Li, Case Western Reserve University, Institute for Computational Biology
2:25 PM
|
Assessing Sensitivity to Unmeasured Confounding with Multiple Treatments and a Binary or Survival Outcome: A Bayesian Approach
Liangyuan Hu, Icahn School of Medicine at Mount Sinai; Chenyang Gu, Harvard Medical School; Michael Lopez , Skidmore College
2:30 PM
|
Development of a Processed Cheese Food Safety Model Using a Response Surface Design and Parametric Survival Modeling
Francis Rossi, PepsiCo
2:45 PM
|
A G-Formula Estimator for Performing Causal Mediation Analysis with Survival Outcomes: Investigating the Relationship Between Statins, Cholesterol and Cardiovascular Diseases
Denis Talbot, Universite Laval; Joseph A Delaney, University of Washington School of Public Health; Veit Sandfort, National Institutes of Health; David M Herrington, Heart and Vascular Center of Excellence; Robyn L McClelland, University of Washington School of Public Health
2:50 PM
|
Simulation-Selection-Extrapolation Estimator for High-Dimensional Errors-In-Variables Models
Linh Nghiem, Southern Methodist University; Cornelis Potgieter, Southern Methodist University
2:50 PM
|
A Nonlinear Model for Censored and Mis-Measured Time-Varying Covariates in Survival Models, with Applications in HIV/AIDS Studies
Hongbin Zhang, City University of New York, School of Public Health; Lang Wu, University of British Columbia
2:50 PM
|
Dynamic Prediction for Patients with High-Grade Extremity Soft Tissue Sarcoma
Anja Rueten-Budde, Leiden University; Marta Fiocco, Leiden University
2:50 PM
|
Analysis of Stratified Clinical Trials with Time-To-Event Endpoints
Devan V Mehrotra, Merck & Co., Inc.; Shanjun Helian, Merck & Co., Inc.; Shu-Chih Su, Merck Research Labs
3:05 PM
|
Penalized Survival Models for the Analysis of Alternating Recurrent Event Data
Lili Wang, University of Michigan, Ann Arbor; Zhi He, University of Michigan; Douglas E. Schaubel, University of Michigan, Ann Arbor
3:05 PM
|
A General Class of Weighted Semiparametric Models for Recurrent Event Data
Russell Stocker, Indiana University of Pennsylvania; Akim Adekpedjou, Missouri University of Science and Technology
3:20 PM
|
Incorporating Auxiliary Information by Joint Modeling of Pseudo Data and Length Biased Data
Yidan Shi, University of Waterloo; Leilei Zeng, University of Waterloo; Mary E. Thompson, University of Waterloo; Suzanne Tyas, University of Waterloo
3:20 PM
|
|
Wednesday, 08/01/2018
|
Statistical Methods to Associate Intra-Tumor Heterogeneity with Clinical Outcomes
Paul Little, UNC Chapel Hill; Danyu Lin, University of North Carolina; Wei Sun, Fred Hutchinson Cancer Research Center
|
The Impact of Analysis Method and Model Specification for Handling Missing Covariate Data in Survival Analysis: a Case Study
Evon Okidi, Brown University; Joseph W Hogan, Brown University School of Public Health; Chanelle Howe, Brown University
|
Causal Inference for Infectious Disease Interventions in Networks
Xiaoxuan Cai, Yale University; Forrest W Crawford, Yale School of Public Health
|
Incidence, Latency, and Survival of Cancer After World Trade Center Exposure: Implementing a Large Epidemiologic Study Involving Many Data Sources
Charles B Hall, Albert Einstein College of Medicine; Rachel Zeig-Owens, Albert Einstein College of Medicine; Amy R. Kahn, Bureau of Cancer Epidemiology, New York State Department of Health; James Cone, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Jiehui Li, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Mark Farfel, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Robert Brackbill, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Paolo Boffetta, Icahn School of Medicine at Mount Sinai
|
A Nonlinear Model for Truncated and Mismeasured Time-Varying Covariates in Joint Models for Longitudinal and Survival Data
Lang Wu, University of British Columbia
8:35 AM
|
Predicting the Timing of the Final Event by Fitting B Splines to Poisson Intensity Rates
Marcus Sobel, Temple Universisity; Ibrahim Turkoz, Janssen Research and Development, LLC
8:35 AM
|
Cox Regression Model Under Dependent Truncation with Applications to Studies of Neurodegenerative Diseases
Lior Rennert, Clemson University; Sharon X Xie, University of Pennsylvania
8:35 AM
|
Bayesian Semiparametric Threshold Regression
Jonathan Race; Michael Pennell, Ohio State University
8:55 AM
|
Semiparametric Estimation of the Cure Fraction in Population-Based Cancer Survival Analysis
Ennan Gu, University of South Carolina; Jiajia Zhang, University of South Carolina
9:05 AM
|
Multiply Imputing Missing Values Arising by Design in Transplant Survival Data
Robin Mitra, University of Lancaster
9:05 AM
|
Improve Risk Prediction Model Estimation with Longitudinal Surrogate Markers
Yu Zheng, Harvard T.H. Chan School of Public Health; Tianxi Cai, Harvard T.H. Chan School of Public Health; Lu Tian, Stanford University School of Medicine
9:15 AM
|
Estimating Personal Cure in Colorectal Cancer Patients Using the SEER Data
Margaret Stedman, Stanford Univ
9:20 AM
|
Causal Inference for Infectious Disease Interventions in Networks
Xiaoxuan Cai, Yale University; Forrest W Crawford, Yale School of Public Health
9:30 AM
|
Censored Threshold Regression with Diverging Number of Covariates
Takumi Saegusa, University of Maryland; Mei-Ling Ting Lee, University of Maryland
9:35 AM
|
Incidence, Latency, and Survival of Cancer After World Trade Center Exposure: Implementing a Large Epidemiologic Study Involving Many Data Sources
Charles B Hall, Albert Einstein College of Medicine; Rachel Zeig-Owens, Albert Einstein College of Medicine; Amy R. Kahn, Bureau of Cancer Epidemiology, New York State Department of Health; James Cone, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Jiehui Li, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Mark Farfel, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Robert Brackbill, World Trade Center Health Registry, New York City Department of Health and Mental Hygiene; Paolo Boffetta, Icahn School of Medicine at Mount Sinai
9:40 AM
|
Genome-Wide Gaussian Process Regression for Survival Time Prediction
Aaron J. Molstad, Fred Hutchinson Cancer Research Center; Wei Sun, Fred Hutchinson Cancer Research Center; Li Hsu, Fred Hutchinson Cancer Research Center, USA
9:50 AM
|
Assessment of Treatment Effect on Overall Survival in the Presence of Treatment Switching: a Bridging Approach Across Various Modeling Methods
Yiyun Tang, Pfizer, Inc.; Selaru Paulina, Pfizer Inc.; Xin Huang, Pfizer Inc.
10:05 AM
|
PROFILE MM ALGORITHMS for GAMMA FRAILTY MODELS
Xifen Huang, University of Hong Kong; jinfeng Xu, The University of Hong Kong
10:05 AM
|
A Functional Proportional Hazards Model for Investigating the Gene-Environment Interaction Effects on Survival
Li Luo, University of New Mexico
10:05 AM
|
Analysis of Lethal Cancer Among a Cohort of Initially Disease-Free Women
Bernard Rosner, Harvard Medical School; Elizabeth Poole, Sanofi
10:35 AM
|
Time-To-Event Data with Time-Varying Biomarkers Measured Only at Study Entry, with Applications to Alzheimer's Disease
Catherine Lee, Kaiser Permanente Division of Research; Rebecca A. Betensky, Harvard School of Public Health
10:50 AM
|
Estimating the Optimal Number and Location of Cut Points in Survival Analysis
Chung Chang, National Sun Yat-sen University
11:05 AM
|
Transformed Dynamic Quantile Regression on Censored Data
Tony Sit, The Chinese University of Hong Kong; Gongjun Xu, University of Michigan; Chi Wing George Chu, Columbia University
11:20 AM
|
Group Sequential Tests of Treatment Effect on Survival and Cumulative Incidence at a Fixed Time Point
Michael Martens, The Emmes Corporation; Brent Logan, Medical College of Wisconsin
11:35 AM
|
Improving Testing and Description of Treatment Effect in Clinical Trials with Time-To-Event Outcomes
Song Yang, NHLBI/NIH
11:50 AM
|
Display Advertising: Estimating Conversion Probability Efficiently
Abdollah Safari, Simon Fraser University; Rachel MacKay Altman, Simon Fraser University; Thomas Loughin, Simon Fraser University
2:35 PM
|
|
Thursday, 08/02/2018
|
Those Who Escaped Must Be Captured: Deconstructing Phylogenies and Transmission Trees in Infectious Disease Epidemiology
Eben Kenah, The Ohio State University School of Public Health
8:55 AM
|
Adjusting for Handling Effects in Microarray Data for Prognostic Biomarker Discovery and Survival Risk Prediction
Ai Ni, Memorial Sloan Kettering Cancer Center; Mengling Liu, New York University; Li-Xuan Qin, Memorial Sloan Kettering Cancer Center
9:05 AM
|
Evaluation of Statistical Methods for Survival Analysis with Time-Dependent Variables
Chris Holland, Amgen; Qui Tran, Amgen; Cassie Dong, Amgen
9:20 AM
|
Frailty Model for Time-To-Event Data on a Social Network
Fangda Song, The Chinese University of Hong Kong; Jing Chu, University of Michigan; Yingying Wei, The Chinese University of Hong Kong
9:20 AM
|
Treatment Heterogeneity and Treatment Eligibility Estimations Using Random Forest Methods
Min Lu, University of Miami; Eugene H. Blackstone, Cleveland Clinic; Hemant Ishwaran, University of Miami
9:35 AM
|
Yakovlev Promotion Time Cure Model with Local Polynomial Estimation
Li-Hsiang Lin, Georgia Tech; Li-Shan Huang, Institute of Statistics, National Tsing Hua University, TAIWAN
9:55 AM
|
Pairwise Accelerated Failure Time Models for Infectious Disease Transmission Within and Between Households
Yushuf Sharker, Yale University; Eben Kenah, The Ohio State University School of Public Health
10:35 AM
|
Survival Models with Compound Random Measures
Fabrizio Leisen, University of Kent
11:15 AM
|
Survival Analysis of Recurrent Events on Prostate Cancer: Facts from Cancer Genome
Munni Begum, Ball State University
11:35 AM
|
On the Parameter Estimation and Modeling of Clustered Survival Data with Delayed Entry and Missing Covariates
Hua Shen, University of Calgary
11:55 AM
|
|
|
